Rituxan IV infusion 500mg (Rituximab) from Zenyaku Kogyo (YJ_code: 4291407A2031, 500mg 50mL 1 bottle) is indicated for conditions such as non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and autoimmune disorders. It functions by targeting specific CD20-positive B cells in the body.
Rituxan IV infusion 500mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
